These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17395705)

  • 1. In vivo analysis of Wnt signaling in bone.
    Glass DA; Karsenty G
    Endocrinology; 2007 Jun; 148(6):2630-4. PubMed ID: 17395705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling and osteoblastogenesis.
    Bodine PV; Komm BS
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.
    Baron R; Rawadi G
    Endocrinology; 2007 Jun; 148(6):2635-43. PubMed ID: 17395698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
    Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
    Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
    Glass DA; Karsenty G
    Curr Top Dev Biol; 2006; 73():43-84. PubMed ID: 16782455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the Wnt signaling pathway in osteoblast commitment and differentiation.
    Yavropoulou MP; Yovos JG
    Hormones (Athens); 2007; 6(4):279-94. PubMed ID: 18055419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
    Glass DA; Karsenty G
    Ann N Y Acad Sci; 2006 Apr; 1068():117-30. PubMed ID: 16831912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling and skeletal development.
    Liu F; Kohlmeier S; Wang CY
    Cell Signal; 2008 Jun; 20(6):999-1009. PubMed ID: 18164181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokines in bone diseases. Wnt signaling and osteoporosis-pseudoglioma syndrome].
    Ozono K
    Clin Calcium; 2010 Oct; 20(10):1520-5. PubMed ID: 20890034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling as a therapeutic target for bone diseases.
    Hoeppner LH; Secreto FJ; Westendorf JJ
    Expert Opin Ther Targets; 2009 Apr; 13(4):485-96. PubMed ID: 19335070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
    Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
    J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling control of bone cell apoptosis.
    Bodine PV
    Cell Res; 2008 Feb; 18(2):248-53. PubMed ID: 18212734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts.
    Liu G; Bafico A; Aaronson SA
    Mol Cell Biol; 2005 May; 25(9):3475-82. PubMed ID: 15831454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wnt signaling and glucocorticoid-induced osteoporosis].
    Ohnaka K
    Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway.
    Jeong YH; Sekiya M; Hirata M; Ye M; Yamagishi A; Lee SM; Kang MJ; Hosoda A; Fukumura T; Kim DH; Saeki S
    Biochem Biophys Res Commun; 2010 Feb; 392(4):495-9. PubMed ID: 20093106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wnt-beta-catenin signaling in bone metabolism].
    Urano T
    Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone.
    Williams BO; Insogna KL
    J Bone Miner Res; 2009 Feb; 24(2):171-8. PubMed ID: 19072724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.
    Chen Y; Whetstone HC; Lin AC; Nadesan P; Wei Q; Poon R; Alman BA
    PLoS Med; 2007 Jul; 4(7):e249. PubMed ID: 17676991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.